Between 2020 and 2024, U.S. phase I clinical trials for non-small cell lung cancer became increasingly concentrated at the top 20 highest‑volume clinical trial sites, according to a study presented by Brittany Avin McKelvey at #AACR26.
https://
brnw.ch/21x1Lrg
@LUNGevity